Disease occurrence, clinical manifestations, and outcomes differ between men and women. Yet, women and men are most of the time treated similarly, which is often based on experimental data over-representing one sex. Accounting for persisting sex bias in biomedical research is the misconception that the analysis of sex-specific effects would double sample size and costs. We designed an analysis to test the potential benefits of a factorial study design in the context of a study including male and female animals. We chose a 2 × 2 factorial design approach to study the effect of treatment, sex, and an interaction term of treatment and sex in a hypothetical situation. We calculated the sample sizes required to detect an effect of a given magnit...
Women and men, female and male animals and cells are biologically different, and acknowledgement o...
Females have long been underrepresented in preclinical research and clinical drug trials. Directives...
This study assessed to what extent women were included in all phases of drug development; whether th...
Disease occurrence, clinical manifestations, and outcomes differ between men and women. Yet, women a...
Summary • BJP now requires sex to be considered as an experimental variable for all experimental re...
Background Growing evidence for clinically significant differences between the sexes has attracted t...
Recently, many funding agencies have released guidelines on the importance of considering sex as a b...
As part of an initiative to improve rigor and reproducibility in biomedical research, the U.S. Natio...
One of the chief advantages of using highly standardised biological models including model organisms...
Female mammals have long been neglected in biomedical research. The NIH mandated enrollment of women...
Study samples should be appropriately selected to maximize generalizability of results. Excluding on...
Abstract Background Cardiovascular disease remains the primary cause of death worldwide. In the US, ...
This is the author accepted manuscript. The final version is available from Nature Research via the ...
Study samples should be appropriately selected to maximize generalizability of results. Excluding on...
International audienceIn recent decades there has been an increasing recognition of the need to acco...
Women and men, female and male animals and cells are biologically different, and acknowledgement o...
Females have long been underrepresented in preclinical research and clinical drug trials. Directives...
This study assessed to what extent women were included in all phases of drug development; whether th...
Disease occurrence, clinical manifestations, and outcomes differ between men and women. Yet, women a...
Summary • BJP now requires sex to be considered as an experimental variable for all experimental re...
Background Growing evidence for clinically significant differences between the sexes has attracted t...
Recently, many funding agencies have released guidelines on the importance of considering sex as a b...
As part of an initiative to improve rigor and reproducibility in biomedical research, the U.S. Natio...
One of the chief advantages of using highly standardised biological models including model organisms...
Female mammals have long been neglected in biomedical research. The NIH mandated enrollment of women...
Study samples should be appropriately selected to maximize generalizability of results. Excluding on...
Abstract Background Cardiovascular disease remains the primary cause of death worldwide. In the US, ...
This is the author accepted manuscript. The final version is available from Nature Research via the ...
Study samples should be appropriately selected to maximize generalizability of results. Excluding on...
International audienceIn recent decades there has been an increasing recognition of the need to acco...
Women and men, female and male animals and cells are biologically different, and acknowledgement o...
Females have long been underrepresented in preclinical research and clinical drug trials. Directives...
This study assessed to what extent women were included in all phases of drug development; whether th...